Richard S Greenberg Insider Trading
Get free email notifications about insider trading for Richard S Greenberg.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Richard S Greenberg. Richard S Greenberg is an Chief Executive Officer in NEXIEN BIOPHARMA, INC. ($NTVA) and a EVP in NEXIEN BIOPHARMA, INC. ($NTVA) and a EVP and Chairman in Kinder Holding Corp. ($KDRH).
Address: 3773 CHERRY CREEK N. DRIVE, SUITE 575 DENVER 80209 CO
Companies in which Richard S Greenberg is an Insider
NEXIEN BIOPHARMA, INC.
Trading Symbol: NTVAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Richard S Greenberg: Chief Executive Officer, EVP and Chairman
Holdings: 3,685,192 shares
Current Value: $36,852
Latest Transaction: Apr 05 2021
$NTVA Market Capitalization: $240726.00
$NTVA Previous Close: $0.01
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Richard S Greenberg
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 05 2021 | NTVA | NEXIEN BIOPHARMA, ... | Greenberg Richard S | Chief Executive Off ... | Grant | A | 0.00 | 1,000,000 | 0 | 3,685,192 | 2.7 M to 3.7 M (+37.24 %) |
Nov 30 2020 | NTVA | NEXIEN BIOPHARMA, ... | Greenberg Richard S | Chief Executive Off ... | Option Exercise | A | 0.05 | 1,062,953 | 48,045 | 1,062,953 | |
Nov 30 2020 | NTVA | NEXIEN BIOPHARMA, ... | Greenberg Richard S | Chief Executive Off ... | Option Exercise | A | 0.04 | 1,062,953 | 46,026 | 1,062,953 | |
Nov 30 2020 | NTVA | NEXIEN BIOPHARMA, ... | Greenberg Richard S | Chief Executive Off ... | Option Exercise | A | 0.04 | 1,062,953 | 42,837 | 1,062,953 | |
Aug 21 2020 | NTVA | NEXIEN BIOPHARMA, ... | Greenberg Richard S | Chief Executive Off ... | Option Exercise | A | 0.08 | 2,500,000 | 200,000 | 2,500,000 | |
Aug 14 2020 | NTVA | NEXIEN BIOPHARMA, ... | Greenberg Richard S | Chief Executive Off ... | Buy | C | 0.01 | 1,800,880 | 25,212 | 2,688,880 | 888 K to 2.7 M (+202.80 %) |
Oct 29 2018 | NTVA | NEXIEN BIOPHARMA, ... | Greenberg Richard S | EVP | Option Exercise | A | 0.66 | 100,000 | 65,500 | 100,000 |